Skip to main content

Table 1 Demographics for the PD and CTL groups

From: Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort

  PD (n = 154) CTL (n = 62) p-value
Age (years) 61.6 ± 8.9 (40–82) 61.5 ± 10 (40–81) 0.87 §
Male distribution 61.7% (98/154) 61.5% (41/62) 0.73 #
Right-handedness 90.3% (139/154) 82.3% (51/62) 0.19 #
Disease duration (months) 25.5 ± 17.8 (2–77) NA
MDS-UPDRS III at baseline 22.3 ± 9.7 (5–46) 0.5 ± 1.2 (0–8) < 0.0001 §
MDS-UPDRS III axial subscore 4.0 ± 2.6 (0–12) 0.1 ± 0.3 (0–2) < 0.0001 §
MDS-UPDRS III right-sided items subscore 7.9 ± 4.8 (0–20) 0.2 ± 0.5 (0–3) < 0.0001 §
MDS-UPDRS III left-sided items subscore 7.7 ± 6.1 (0–23) 0.3 ± 0.6 (0–3) < 0.0001 §
Hoehn-Yahr scale 1.5 ± 0.5 (1–2) 0 (0–0) < 0.001 #
MOCA 27.4 ± 2.2 (20–30) 28.2 ± 1.2 (26–30) 0.19 §
GDS 5.3 ± 1.4 (1–11) 5.1 ± 1.2 (3–10) 0.39 §
SCOPA-AUT 10.5 ± 6.0 (0–40) 7.5 ± 4.5 (0–19) 0.0002 §
SCOPA-AUT Gastrointestinal subscore 2.3 ± 1.9 (0–11) 0.8 ± 1.0 (0–4) <  0.0001 §
SCOPA-AUT Urological subscore 3.9 ± 2.5 (0–14) 3.2 ± 2.3 (0–12) 0.03 §
Epworth Sleepiness Scale 6.2 ± 4.0 (0–19) 5.9 ± 3.3 (0–15) 0.68 §
REM-sleep behavior disorder screening questionnaire 4.3 ± 2.6 (1–12) 2.9 ± 2.2 (0–10) <  0.001 §
  1. Baseline demographics of PD and CTL subjects included in the study. Statistical tests: Chi-square #, Mann-Whitney U test §. NA not applicable